Bioventus Inc. (BVS)
NASDAQ: BVS · Real-Time Price · USD
12.91
+0.28 (2.22%)
Sep 18, 2026, 4:00 PM EDT - Market closed
Bioventus Market Cap
Bioventus has a market cap or net worth of $1.09 billion as of September 18, 2026. Its market cap has increased by 134.19% in one year.
Market Cap
1.09B
Enterprise Value
1.32B
1-Year Change
134.19%
Ranking
Category
Stock Price
$12.91
ChartMarket Cap Chart
Since the IPO on February 11, 2021, Bioventus's market cap has increased from $713.47M to $1.09B, an increase of 52.16%. That is a compound annual growth rate of 7.78%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 881.82M | 76.96% |
| Dec 31, 2025 | 498.30M | -27.40% |
| Dec 31, 2024 | 686.36M | 106.84% |
| Dec 29, 2023 | 331.83M | 105.22% |
| Dec 30, 2022 | 161.69M | -81.23% |
| Dec 31, 2021 | 861.26M | 20.71% |
| Feb 11, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Tandem Diabetes Care | 1.20B |
| Integra LifeSciences Holdings | 1.17B |
| Artivion | 1.16B |
| PROCEPT BioRobotics | 1.12B |
| Lumexa Imaging Holdings | 1.11B |
| IRADIMED CORPORATION | 1.06B |
| Enovis | 1.03B |
| Beta Bionics | 964.13M |